1. Home
  2. List
Reference Patent

Reference - List

  • 12 Hits
  • Search Condition : Filter (MeSH = Retinal Neoplasms / pathology)
Species Resource Title
Human and Animal Cells Y79(RCB1645) Carboplatin- and Etoposide-Loaded Lactoferrin Protein Nanoparticles for Targeting Cancer Stem Cells in Retinoblastoma In Vitro.
Human and Animal Cells Y79(RCB1645) , WERI-Rb-1(RCB2146) Synergistic Effect of Curcumin in Combination with Anticancer Agents in Human Retinoblastoma Cancer Cell Lines.
Human and Animal Cells WERI-Rb-1(RCB2146) , NCC-RbC-51(RCB2206) Gene expression profiling of tumor stroma interactions in retinoblastoma.
Human and Animal Cells Y79(RCB1645) Targeting HSP90/Survivin using a cell permeable structure based peptido-mimetic shepherdin in retinoblastoma.
Human and Animal Cells WERI-Rb-1(RCB2146) , Y79(RCB1645) BAG3 protects against hyperthermic stress by modulating NF-κB and ERK activities in human retinoblastoma cells.
Human and Animal Cells Y79(RCB1645) , WERI-Rb-1(RCB2146) Inhibition of polo-like kinase 1 promotes hyperthermia sensitivity via inactivation of heat shock transcription factor 1 in human retinoblastoma cells.
Human and Animal Cells Y79 , WERI-Rb-1(RCB2146) Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer.
Human and Animal Cells Y79(RCB1645) Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.
Human and Animal Cells Y79(RCB0427) An experimental application of gene therapy for human retinoblastoma.
Human and Animal Cells Y79(RCB1645) Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.
Human and Animal Cells Y79(RCB1645) Reversal of stathmin-mediated microtubule destabilization sensitizes retinoblastoma cells to a low dose of antimicrotubule agents: a novel synergistic therapeutic intervention.
Human and Animal Cells WERI-Rb-1(RCB2146) , Y79(RCB1645) Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.